GSK wins U.S. nod for two-drug HIV combination

GlaxoSmithKline Plc's two-drug treatment for HIV infections won U.S. market approval on Monday, boosting the British drugmaker's growth prospects against competitor Gilead Sciences Inc.

from Reuters: Health News https://reut.rs/2D3NxWh
via IFTTT